2014

Medbox Sponsors Drugstore News' Collaborative Care Continuing Education Webinar Course provides Continuing Education Credit for Pharmacists

WEST HOLLYWOOD, Calif., Dec. 17, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented systems to the medical and retail industries, announced that they will be the sponsor of Drugstore News' Collaborative Care Continuing Education Webinar. The course will be held tonight, December 17, 2013 at 8:30 pm EST.

The program is titled "Medical Marijuana in the United States: New Issues for an Old Plant." The course is designed for pharmacists, and provides a full Continuing Education (CE) credit.

The course instructor is Laura M. Borgelt, PharmD, FCCP, BCPS, NCMP, Associate Professor, Departments of Clinical Pharmacy and Family Medicine, University of Colorado, Anschutz Medical Campus.

The program goal is to provide pharmacists an update on the regulatory parameters of marijuana and its characteristics and effects on patients.

Upon completion of this program, the pharmacist should be able to:

  1. Compare and contrast regulatory issues for use of marijuana in various states.
  2. Describe the clinical pharmacology of marijuana and its active components.
  3. Explain the various dosage forms of marijuana and their pharmacodynamic impact.
  4. Evaluate the potential therapeutic and adverse effects of marijuana.
  5. Identify potential drug interactions and consumer safety issues with marijuana use.

The course is offered free of charge to pharmacists. After tonight's live webinar, the course will be available as a home study for the next 2-years.

"We are pleased to be able to sponsor this educational seminar," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "As the industry's leading advocate of compliance, transparency, and efficacy, we applaud this opportunity for pharmacists to gain valuable information about the pharmacology of marijuana." 

In other news, Medbox announced that they were pleased to be a question on the popular television program, "Jeopardy."  On the Monday night program (December 16, 2013), the "question" asked: "The Medbox Co. has created a machine that dispenses this plant for medicinal purposes & brownies too!"

"We are very proud of the fact that we were featured as a question on Jeopardy," Bedrick exclaimed. "I have always loved this program, and being a part of it means that we've become a part of the American Lexicon," he added. "I couldn't be more thrilled."

To register for the Pharmacist Webinar, visit:
https://event.webcasts.com/viewer/landing.jsp?ei=1026351  

For more information on Medbox, call (800) 762-1452 or go online to www.medboxinc.com.

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Florida, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.

SOURCE Medbox, Inc.



RELATED LINKS
http://www.medboxinc.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.